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Cyclic vomiting syndrome is characterized by recurrent episodes of stereotyped vomiting separated by regular 
symptom-free periods. We describe a case of cyclic vomiting syndrome developed after stroke, which has not been 
reported to date. A 69-year-old woman experienced recurrent vomiting following left cerebral infarct. Th  e  patient’s 
vomiting pattern was consistent with cyclic vomiting syndrome, and the diagnosis of cyclic vomiting syndrome 
was established by exclusion of other known disorders which could have resulted in vomiting. She was treated 
with imipramine hydrochloride and her symptom was well controlled.
Key Words  Cyclic vomiting syndrome, Stroke
Annals of Rehabilitation Medicine
Case Report
Ann Rehabil Med 2012; 36: 141-143
pISSN: 2234-0645 • eISSN: 2234-0653
http://dx.doi.org/10.5535/arm.2012.36.1.141
INTRODUCTION
Cyclic vomiting syndrome (CVS) is characterized by re-
current episodes of repetitive and stereotyped vomiting 
separated by regular symptom-free periods.
1 Th  e  diagno-
sis of CVS is primarily based on history and clinical pre-
sentation. CVS is diagnosed if the following conditions 
are satisfied: stereotypical episodes of vomiting marked 
by sudden or acute onset with a duration <1 week, 3 or 
more discrete episodes, no evidence of organic problems, 
and absence of symptoms between attacks.
1,2
Although the pathophysiology of CVS has not been 
clarified, several hypotheses have been suggested. The 
current theory is that CVS is a functional brain-gut dis-
order involving central neuroendocrine and peripheral 
gastrointestinal mediation.
1,3 Anatomical structures 
responsible for vomiting are neurons within the hypo-
thalamus, the pituitary gland, and the brainstem. If the 
organic problems related to these structures, such as 
hydrocephalus, brain tumor, and Budd-Chiari malforma-
tion are implicated, CVS should be excluded according 
to the diagnostic criteria.
1,4 We present a patient in whom 
CVS developed following stroke in a region not previously 
associated with vomiting. To our knowledge, CVS related 
to a stroke has not been previously reported.
CASE REPORT
A 69-year-old woman was admitted complaining of 
sudden deterioration of right pre-existing hemiplegia 
(day 1). She continued to have mild right hemiplegia af-
ter 2 previous strokes. Apart from diabetes mellitus, there 
was no other remarkable medical history. Brain magnetic 
resonance imaging showed acute infarct in the left coro-
na radiata, which was surrounded by chronic infarct. Th  e 
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left ventricle was asymmetrically enlarged due to peri-
ventricular tissue loss. Th   ere was bilateral leukoaraiosis. 
No abnormal fi  ndings could be seen in structures known 
to be associated with vomiting (hypothalamus, pituitary 
gland, and brainstem). After admission, recurrent vomit-
ing developed at intervals of -1 week. Th   e follow-up mag-
netic resonance imaging was unchanged.
On day 39, she was transferred to our department for re-
habilitation. She was alert and her Mini-Mental State Ex-
amination score was 19/30. On neurologic examination, 
she had right hemiparesis with sensory abnormalities, 
accompanied by right facial palsy and mild dysarthria 
without aphasia. Deep tendon reflexes were increased 
in the right limbs. She did not complain of abdominal 
symptoms, nor was there anorexia, nausea, diarrhea, or 
constipation.
During rehabilitation, sudden vomiting continued at 
intervals of -1 week. Th   e vomiting was repetitive and ste-
reotyped. She denied vomiting prior to the recent stroke. 
The vomiting rapidly developed following nausea and 
abdominal discomfort, during or after taking medica-
tions in the morning. Th   e repeated vomiting occurred 2 
or 3 times over a period of 1 hour. After cessation of the 
vomiting, associated anorexia and anxiety disappeared 
during the next 24 hours. During intervals of 1 week, the 
patient was free of associated episodes. Treatment with 
metoclopramide and mosapride was not eff  ective. Tests 
for blood sugar, serum glucose, and hemoglobin A1c 
were consistently normal. To be diagnosed with CVS, 
various other disorders that can produce cyclic vomit-
ing should be excluded, such as gastrointestinal, renal, 
neurologic, and endocrinologic disorders.
1 To rule out 
other conditions associated with cyclic vomiting, she un-
derwent brain magnetic resonance imaging, laboratory 
tests, simple abdominal x-ray, gastric endoscopy, and 
abdominal and pelvic ultrasonographies. Results for all 
diagnostic tests were unremarkable. 
Based on the typical symptoms and examinations, she 
was diagnosed as having CVS. On day 86, the patient 
was treated with imipramine hydrochloride (25 mg) at 
bedtime. There were no side effects of imipramine hy-
drochloride. The dose of this medication was gradually 
increased to 50 mg at bedtime. Eventually, her symptom 
was controlled. 
DISCUSSION
Th   e symptoms of the patient were consistent with CVS. 
CVS consists of an inter-episodic phase (without any 
symptoms), a prodromal phase, an emetic phase, and 
a recovery phase (from subsidence of the vomiting to 
returning to normal).
5 Th   e patient had an inter-episodic 
phase of -1 week in duration. Th   e prodromal symptoms 
consisted of nausea and abdominal discomfort which 
started when the patient began to sense the approach 
of the episodes. Th   ese symptoms are the most common 
prodromal symptoms of CVS.
5 Th   e duration of the emetic 
phase was 1 hour, with all of the vomiting occurring in 
the morning. This is a typical feature of CVS.
5 This phe-
nomenon is due to a characteristic of the neuroendo-
crine system, which is based on the theory of brain-gut 
disorder. The important regions for brain-gut disorder 
are thought to lie within the hypothalamus and the peri-
aqueductal gray matter of the brainstem. Th   e former con-
trols the release of corticotrophin-releasing hormone in 
response to stress and the latter controls the autonomic 
function.
3 The interaction between the peripheral affer-
ent stimuli from the gut and these brain regions regulates 
vomiting. The brain-gut disorder reflects a current hy-
pothesis that in CVS, there is a dysfunction of this inter-
action.
1,3-5 Th   e basal secretion of corticotrophin-releasing 
hormone has a diurnal rhythm. Secretion of the hormone 
begins to increase at 1 AM and reaches a peak at 6 AM. 
This may account for the predominance in morning 
times of the onset of CVS.
1 Many patients with CVS have 
a triggering factor.
1,3,5 Th   e triggering factor in our patient 
was the morning medication. The patient did not have 
any other symptoms associated with the medication or 
inter-episodic phase without the episode. Based on these 
fi  ndings, the possibility that cyclic vomiting resulted from 
the drug was less likely. Th   e patient had a recovery phase 
that lasted for a day, and there were anorexia and anxiety 
during the phase.
Th   e diagnosis of CVS requires that various organic dis-
orders associated with a vomiting should be excluded; 
these disorders include gastrointestinal, renal, neurolog-
ic, and endocrinologic disorders.
1 For diagnosis of CVS, 
our patient underwent brain magnetic resonance imag-
ing, laboratory tests, simple abdominal x-ray, gastric en-
doscopy, and abdominal and pelvic ultrasonographies. 
Magnetic resonance imaging excluded neurologic disor-Cyclic Vomiting Syndrome after Stroke
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ders such as hydrocephalus, brain tumor, and Budd-Chi-
ari malformation. Laboratory tests including complete 
blood count, urine analysis, and chest x-ray excluded in-
fections. Laboratory hormonal tests excluded endocrino-
logic disorders. Gastric endoscopy excluded esophageal 
disorders and peptic ulcer disease. Simple abdominal 
x-ray excluded bowel obstruction and ileus. Abdominal 
ultrasonography and laboratory tests that included liver 
function tests, excluded gastrointestinal disorders such 
as hepatitis, pancreatitis, cholelithiasis, tumors, and 
renal disorders. Pelvic ultrasonography excluded gyne-
cologic disorders, such as ovarian cyst. Absence of ab-
dominal symptoms such as diarrhea and abdominal pain 
excluded motility disorders and infl  ammatory bowel dis-
ease. Th   ere was a limitation of this study. Th   e patient was 
elderly. Functional disorders associated with the delay of 
emptying of gastric and small bowel should also be ex-
cluded. We did not perform functional studies. However, 
clinical findings of cyclic vomiting and inter-episodic 
phases without any symptoms supported that there was 
very little likelihood of such disorders.
It has been well known that neuroendocrine and au-
tonomic dysfunction develop after stroke, although the 
etiologies have not been definitely demonstrated.
6-8 Pe-
ripheral aff  erent stimuli of the gastro-intestine are regu-
lated by vagal aff  erent signals which are controlled by the 
autonomic system.
4 
No standard evidence-based regimen currently exists 
to treat CVS.
1 The treatment is based on the phases of 
CVS. Th   e best treatment is to prevent the episodes of CVS 
during inter-episodic phases.
1,2,5 A tricyclic antidepres-
sant which decreases cholinergic neurotransmission 
in the medulla is widely used in the phase. Thus, the 
medication can modify the brain-gut axis and autonomic 
dysfunction, a possible pathomechanism for CVS.
2 Our 
patient completely recovered with the medication.
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